Clinical Trials in North Carolina

Showing 11641-11660 of 20,428 trials

Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

NCT01103037

This study will assess the safety and efficacy of QAV680 in patients with mild to moderate asthma

Novartis Pharmaceuticals8 participantsStarted Mar 2010

Cypress, California, United States • Charlotte, North Carolina, United States • Raleigh, North Carolina, United States +4 more locations

COMPLETEDPhase 366 miles

8-Week Atopic Dermatitis (AD) Treatment Study

NCT03386032

This is a study to investigate the clinical effectiveness of the Sponsor's experimental cream treatment on eczema as measured by visual grading of SCORAD (scoring of atopic dermatitis).

Atopic Dermatitis Eczema

Procter and Gamble65 participantsStarted Nov 2017

Raleigh, North Carolina, United States • Chattanooga, Tennessee, United States

COMPLETEDPhase 2197 miles

Dose Finding Study for QAW039 in Asthma

NCT01437735

This study aims to demonstrate a clinically significant improvement in Forced Expiratory Volume in one second (FEV1) in moderate to severe allergic asthmatics inadequately controlled by Inhaled Corticosteroid (ICS) therapy. Patients will be treated with QAW039, an active comparator, or placebo. This will be a randomized, placebo-controlled, dose-ranging, multi-centre trial.

Asthma

Novartis Pharmaceuticals1,043 participantsStarted Aug 2011

Scottsdale, Arizona, United States • Encinitas, California, United States • Huntington Beach, California, United States +203 more locations

Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

8-Week Atopic Dermatitis (AD) Treatment Study

Dose Finding Study for QAW039 in Asthma

Find Trials by Condition in North Carolina

Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients

LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma.

A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder

Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) Scale

Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)

A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma.

A Biobehavioral Intervention for Young Men With Testicular Cancer

Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients

Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function

A Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults

Effect of Hepatic Impairment on LDE225..

PCA062 in pCAD-positive Tumors.

A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.

Pharmacokinetics of rFVIIIFc at Two Vial Strengths

A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors

Efficacy and Safety of BGG492 in the Treatment of Migraine